Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Springer
F L Brown
S Scott

Showing results (561-570 of 2,906) with videos related to

Pageof 291
Sort By:
Diabetes Research and Clinical Practice|May 1, 1987
No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetesR S Scott, T Donnelly
Cell Biophysics|January 1, 1994
Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenograftsS K Sharma, J A Boden, C J Springer, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1988
Effects of vasoactive intestinal polypeptide infusions on renal function in patients with liver diseaseJ Calam, R J Unwin, S Dorudi, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Analysis of Neutrophil Bactericidal ActivityNicholas J Magon, Heather A Parker, Louisa V Ashby, et al.
Nature Biotechnology|January 7, 1998
A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapyR Marais, R A Spooner, S M Stribbling, et al.
Special Libraries|March 13, 1978
Drug information to patient care areas via television: preliminary evaluation of two years' experienceS J Springer, R A Yokel, N M Lorenzi, et al.
International Journal of Cancer|June 8, 2001
Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapyR A Spooner, K A Maycroft, H Paterson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 1991
Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitisC J Springer, G A Eberlein, V E Eysselein, et al.
Human Gene Therapy|April 10, 1997
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metaboliteJ A Bridgewater, R J Knox, J D Pitts, et al.
Journal of Medicinal Chemistry|February 1, 1990
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2C J Springer, P Antoniw, K D Bagshawe, et al.
Pageof 291

Showing results (561-570 of 2,906) with videos related to

Sort By:
Pageof 291
Diabetes Research and Clinical Practice|May 1, 1987
No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetesR S Scott, T Donnelly
Cell Biophysics|January 1, 1994
Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenograftsS K Sharma, J A Boden, C J Springer, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1988
Effects of vasoactive intestinal polypeptide infusions on renal function in patients with liver diseaseJ Calam, R J Unwin, S Dorudi, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Analysis of Neutrophil Bactericidal ActivityNicholas J Magon, Heather A Parker, Louisa V Ashby, et al.
Nature Biotechnology|January 7, 1998
A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapyR Marais, R A Spooner, S M Stribbling, et al.
Special Libraries|March 13, 1978
Drug information to patient care areas via television: preliminary evaluation of two years' experienceS J Springer, R A Yokel, N M Lorenzi, et al.
International Journal of Cancer|June 8, 2001
Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapyR A Spooner, K A Maycroft, H Paterson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 1991
Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitisC J Springer, G A Eberlein, V E Eysselein, et al.
Human Gene Therapy|April 10, 1997
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metaboliteJ A Bridgewater, R J Knox, J D Pitts, et al.
Journal of Medicinal Chemistry|February 1, 1990
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2C J Springer, P Antoniw, K D Bagshawe, et al.
Pageof 291